Mayflower Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
208,112
+200,153
+2,515% +$11.5M 1.04% 24
2026
Q1
$483K Buy
7,959
+258
+3% +$15K 0.06% 267
2025
Q4
$415K Sell
7,701
-189
-2% -$9.09K 0.05% 276
2025
Q3
$356K Sell
7,890
-548
-6% -$25.6K 0.04% 309
2025
Q2
$391K Sell
8,438
-7,496
-47% -$368K 0.05% 273
2025
Q1
$972K Buy
15,934
+4,252
+36% +$248K 0.15% 148
2024
Q4
$661K Buy
11,682
+3,216
+38% +$180K 0.1% 188
2024
Q3
$438K Buy
8,466
+192
+2% +$9.01K 0.07% 243
2024
Q2
$344K Sell
8,274
-1,149
-12% -$51.4K 0.06% 266
2024
Q1
$511K Sell
9,423
-203,960
-96% -$10.4M 0.09% 209
2023
Q4
$10.9M Sell
213,383
-1,477
-0.7% -$77.5K 1.51% 13
2023
Q3
$12.5M Sell
214,860
-48
-0% -$2.94K 1.87% 13
2023
Q2
$13.7M Sell
214,908
-222
-0.1% -$14.9K 1.78% 11
2023
Q1
$14.9M Sell
215,130
-1,238
-0.6% -$87.3K 1.96% 11
2022
Q4
$15.6M Sell
216,368
-9,819
-4% -$740K 2.16% 8
2022
Q3
$16.1M Buy
226,187
+165
+0.1% +$12K 2.59% 6
2022
Q2
$17.4M Sell
226,022
-99
-0% -$7.54K 2.67% 5
2022
Q1
$16.5M Buy
226,121
+726
+0.3% +$48.7K 2.22% 9
2021
Q4
$14.1M Sell
225,395
-203
-0.1% -$11.9K 1.87% 9
2021
Q3
$13M Buy
225,598
+48
+0% +$3.16K 1.75% 12
2021
Q2
$15.1M Buy
225,550
+11,690
+5% +$762K 2.07% 9
2021
Q1
$13.5M Buy
213,860
+315
+0.1% +$19.6K 2% 11
2020
Q4
$13.2M Buy
+213,545
New +$13.1M 2.29% 10

Other funds holding BMY

Mayflower Financial Advisors's BMY Position: Q2 2026 in Review

Mayflower Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 2,515% in Q2 2026, buying an estimated $11.5M and bringing the position to 208,112 shares worth $12M. The position accounts for 1.04% of the portfolio, ranked #24.

Mayflower Financial Advisors first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $17.4M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Mayflower Financial Advisors held 208,112 shares of Bristol-Myers Squibb worth $12M as of Q2 2026.
  • Mayflower Financial Advisors bought 200,153 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5M.
  • Bristol-Myers Squibb made up 1.04% of Mayflower Financial Advisors's portfolio in Q2 2026, its #24 holding.
  • Mayflower Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Mayflower Financial Advisors's Bristol-Myers Squibb position peaked at $17.4M in Q2 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.